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Evaluation of Fc∈RI-bindable human IgE with an
enzyme-linked immunosorbent assay using a
recombinant soluble form of the human
Fc∈RIα ectodomain
Naruhito Wada,Ko Okumura and Chisei Ra
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ABSTRACT
To estimate the levels of serum IgE that is actually
able to be bound to Fc∈RI, we developed a novel
enzyme-linked immunosorbent a say(ELISA)using a
recombinant soluble form of the human Fc∈RIα
ectodomain(soluble α-ELISA). We evaluated the levels
of Fc∈RI-bindable serum IgE in normal volunteers and
in patients with atopic dermatitis and bronchial
asthma, and compared them with those of total IgE
measured by a conventional sandwich-ELISA. There
was a striking difference between the IgE values
evaluated with these two ELISA systems. In most of the
sera,the IgE values evaluated with the soluble α-ELISA
were substantially lower than those evaluated with the
sandwich-ELISA.Our results indicate that all serum
IgE(especially in hyper-IgE sera) does not necessarily
bind to the Fc∈RI and that it will be useful to evaluate
Fc∈RI-bindable IgE for further analysis of allergic
states.
Key words: allergy,enzyme-linked immunosorbent
assay,Fc∈RI,Fc∈RI-bindable IgE,immunoglobulin E,
soluble human Fc∈RIα ectodomain.
INTRODUCTION
Immunoglobulin E(IgE) is the critical antibody that elicits
the type I allergic reaction when it binds to the high
affinity receptor for IgE (Fc∈RI) on the surface of mast
cells and basophils and cross-linked with multivalent
allergens.Therefore,it would be useful to estimate the
actual IgE able to bind to Fc∈RI for a detailed analysis of
type I allergy.
There was one report published 20 years ago
documenting that the number of cell-bindable IgE
molecules did not always correlate with serum IgE levels
in atopic individuals.1 A few other reports have presented
further evidence that serum IgE molecules may be
heterogenous with respect to cell-binding and histamine-
releasing properties in passive cutaneous anaphylaxis
(PCA) reactions.2-5 Taking these reports into considera-
tion,all serum IgE molecules may not always bind to
Fc∈RI on the cell surface and may not always evoke an
allergic reaction.This heterogeneity of serum IgE may be
explained by the possible occurrence of Fc∈RI-bindable
and non-bindable IgE molecules in sera.Anti-IgE
autoantibodies,6-9 anti-Fc∈RIα chain autoantibodies10
and/or other IgE-binding molecules,such as soluble
CD23(Fc∈RII,the low-affinity receptor for IgE)11 and 60
kDa IgE-binding component,12 were also detected in the
sera of allergic patients. In addition,epsilon binding
protein/macrophage differentiation antigen-2(∈BP/
Mac-2),which can bind to both IgE and Fc∈RI, has been
detected in the sera in a soluble form.13-16 These auto-
antibodies and IgE-binding proteins in the sera may
block IgE-binding to Fc∈RI and may modulate allergic
reactions.
As one of the useful means for the clinical diagnosis of
allergy,enzyme-linked immunosorbent assay(ELISA)
systems to evaluate serum IgE levels are widely used.
However,present ELISA systems do not indicate whether
the IgE measured by these systems is able to bind to Fc∈RI
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or not.It is important to evaluate the levels of serum IgE
that can bind to Fc∈RI for the further estimation of the
allergic state,with regard to factors that block IgE-
binding to Fc∈RI.For this purpose we have developed a
novel ELISA system to detect Fc∈RI-bindable IgE using a
recombinant soluble form of the α-subunit of human
Fc∈RI (soluble α-ELISA).
Fc∈RI has a tetrameric structure composed of one α.-,
one β-and two disulfide-linked ・γ-subunits,17,18 of which
the α-subunit binds lgE with high affinity.A recombinant
soluble form of the ectodomain of the human Fc∈RIα
subunit (soluble α) was recently generated by gene
engineering and was produced by transfected
mammalian cells,19-21 insect cells and yeast.22 Soluble α is
shown to bind IgE with an affinity as high as that of native
Fc∈RI and the binding stoichiometry is confirmed to
be l:1.21,23
Serum ＩgE bound onto the soluble α(the product of
CHO transfectants23)was detected by an anti-IgE
polyclonal antibody.As,in this assay system,IgE binds
directly to its specific binding site on the Fc∈RIα,we
could,for the first time,estimate Fc∈RI-bindable IgE.We
evaluated levels of Fc∈RI-bindable IgE in sera from
normal subjects and in sera from patients with atopic
dermatitis and bronchial asthma and compared the
values of Fc∈RI-bindable IgE with those of total IgE
measured by a conventional sandwich-ELISA using two
different antibodies against IgE.
METHODS
Serum samples
Sera were obtained from peripheral blood samples taken
from 127 individuals who had given their informed
consent.Serum samples were stored at-20℃ until use.
Five serum samples from normal subjects with no allergic
diseases,24 serum samples from patients with atopic
dermatitis and 98 serum samples from patients with
bronchial asthma were analyzed in the present study.
Briefly,peripheral venous blood was taken and left on
ice for 1h and was then centrifuged at 300g at 4℃ for
20min to separate the serum.
ELISA to detect Fc∈RI-bindable IgE using
soluble α
Ninety-six-well microtiter plates (lmmulon 2; Dynatech
Laboratories,Chantilly,VA,USA) were coated with
90ng/100μL per well soluble α in coating buffer at 4℃
overnight.This soluble α was purified from the culture
sup rnatant of CHO transfectants secreting soluble a, as 
previously described.23 Briefly, soluble a was purified by a 
mouse IgE-Affigel-10 column (Bio-Rad Laboratories, 
Richmond, CA, USA) and gel filtration through a 
S phacryl S-200 column (Pharmacia Fine Chemicals AB,
Uppsala,Sweden).The wells were washed five times with
the washing buffer,blocked with the blocking buffer at
37℃ f r 1h and washed again five times with the
washing buffer.The serially diluted IgE standard (100
μL/well) or diluted sera in dilution buffer were added to
the wells and were in cubated at 37℃ for 3h. Briefly,this
s andard IgE was purified from the serum of IgE-myeloma
by a combination oaf ammonium sulfate precipitation,gel
and ion-exchange chromatography and immuno-
adsorbents,as described previously.24 Wells were washed
five times with the washing buffer and were then
incubated With horseradish-peroxidase (HRP)-label d
goat anti-human IgE polyclonal antibody (Organon
Teknica Corp.,Durham,NC,USA;diluted 1/1000 with
dilution buffer)at 37℃ for 1h.After washing,the
substrate solution(100μL/well)was finally added and
th  plates were incubated at room temperature for 10
min.To stop the reaction,25μL/well of 2mol/L H2SO4
(25μL/well) was added.Optical absorbance of the
samples was measured at a wavelength of 450nm using 
a Bio-Rad microplate reader (model 450; Bio-Rad 
Laboratories, Richmond, CA, USA) with a 450nm filter. 
All assays were performed in triplicate and the standard 
deviation was below 5%.
 The buffers used in this assay are as follows: (i) coating 
buffer: 50mmol/L carbonate buffer, pH 9.4; (ii) 
phosphate-buffered saline (PBS): 10mmol/L phosphate 
buffer containing 0.15mol/L NaCI, pH 7.2; (iii) washing 
buff r: PBS c ntaining 0.05% (v/v) Tween-20 (Wako Pure 
Chemical Industries Ltd, Osaka, Japan); (iv) dilution
buffer: PBS containing 0.1% (w/v) casein (skimmed milk; 
Snow Brand Industries Co. Ltd, Sapporo, Japan); (v) 
blocking buffer: PBS containing 1% (w/v) casein and 
0.02% (w/v) NaN3; (vi) substrate buffer: 10mmol/L 
sodium acetate buffer, pH 5.8; and (vi) substrate 
solution: 3,3',5,5'-tetramethyl-benzidine (TMBZ; Wako 
Pure Chemical Industries Ltd) 0.1mg/mL in substrate 
buffer containing 0.0075% (w/v) H2O2.
Conventional sandwich-ELISA to detect
total IgE
Sandwich-ELISA was performed using an ELISA(R)-IgE kit
(International Reagents Corp., Kobe, Japan) following 
the manufacturer's inst uctions. Serially diluted standard
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IgE or the diluted sera in dilution buffer(200μL/well)
were added to the wells coated with a mouse anti-human 
IgE monoclonal antibody. The plates were incubated at 
room temperature for 1h, washed five times with 
washing buffer and then further incubated with a 
HRP-labeled anti-human IgE polyclonal antibody (Ab) 
at room temperature for 30min. After washing,
100μL/well substrate solution (ortho-phenylene diamine
(OPD); 2mg/mL in substrate buffer) was added and the 
plates were incubated in the dark at room temperature 
for 30min; 2mol/L H2SO4 was added to stop the 
reaction. Optical absorbance was measured at a 
wavelength of 490nm using a Bio-Rad microplate 
reader (model 450) with a 490nm filter. All assays were 
performed in triplicate and the standard deviation was 
below 5%.
Effect of soluble Fc∈RII/CD23 on the evaluation
of IgE by soluble α-ELISA
The effect of soluble CD23 was examined by adding 
soluble CD23 (T Cell Diagnostics Inc., Cambridge, MA, 
USA) to sample sera at various concentrations when
evaluating IgE by the soluble α-ELISA.
Soluble CD23 dilutions were mixed with the sample
sera,incubated at 37℃ for 2h and the mixture was
added to the soluble α-coated plate.
The following steps of the soluble α-ELISA were the
same as those described above.The levels of serum
Fc∈RII/CD23 were determined usina the CD23 test kit(T
Cell Diagnostics, Inc.) following the manufacturer's 
instructions.
Statistical analysis
The data of the calibration curves, shown in Fig. 2, and o' 
the stability of the serum IgE, shown in Fig. 3, were 
statistically analyzed by the Student's t-test. A probability 
of 5% or less was considered significant. The data of 
comparisons of serum IgE values, shown in Fig. 4, were 
statistically analyzed by Fisher's Z-transformation. A 
probability of 1% or less was considered significant 
These analyses were performed by using Stat View II(R) 
(Abacus Concepts Inc., Berkeley, CA, USA).
RESULTS
compatibility f soluble α-and conventional
sandwich-ELISA
Representative calibration curves of the standard IgE
generated by soluble α-and conventional sandwich-
ELISA are presented in Fig. 1a,b, respectively.The
sensitivity of the solubie α-ELISA was 300pg and that of
the sandwich-ELISA w s 1.5ng.
In the beginning,we had plotted 10 doses of the
diluted standard IgE for generating the calibration curves
by soluble α-ELISA and compared these calibration
curves with those of five doses,as shown in Fig.1.As
Fig. 1 Calibration curves of the standard IgE generated by (a) soluble a-ELISA and (b) conventional sandwich-ELISA. Calibration 
curves were generated each time when IgE measurements were performed.
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there had been almost no difference between them, we 
subsequently used five doses of standard IgE for 
generating standard curves each time.
 Standard IgE, HRP-labeled anti-human IgE Ab and 
enzyme substrate applied in these two ELISA systems were 
different from each other, as described in Methods; 
therefore, we first tried to confirm the compatibility of 
these two ELISA systems by comparing the calibration 
curves of both ELISA when the reagents were exchanged 
between them. The calibration curves shown in Fig. 2a 
were generated by the sandwich-ELISA using two different 
IgE, the first was a myeloma IgE originally used in the
soluble α-ELISA and the second was the IgE supplied in
the sandwich-ELISA kit. The concentration of the latter IgE 
was originally shown as international units (IU), but we 
converted it to represent an absolute amount (ng) with the 
following equation: 25-28
1 IU IgE=2.4ng IgE
 As shown in Fig. 2a, there was almost no difference 
between the two standard curves using two different IgE 
with all other reagents of the kit as mentioned above. For 
the sandwich-ELISA, we next used the HRP-labeled anti-
human IgE Ab (Organon Teknica Corp.), which was
originally used in the solubleα-ELISA, and admost the
same standard curves were obtained with the two 
different standard IgE (data not shown). We subsequently 
generated calibration curves using the same HRP-labeled
anti-human IgE Ab and the same substrate for HRP
(TMBZ)in both soluble α-and sandwich-ELISA.As shown
in Fig.2b,c (soluble α-ELISA and sandwich-ELISA,
respectively), there was almost no difference between
each calibration curve, indicating that we can compare
the IgE values estimated by each ELISA system despite
using different reagents.
  Based on these results, we evaluated serum IgE levels
with these two ELISA systems using different reagents and
compared those IgE values with each other.
Stability of serum IgE for binding to Fc∈RIα
As it is well known that the binding activity of IgE to the 
cell surface is easily lost under some conditions, such as
high temperature(56℃,30min: heat inactivation), we
examined the stability of serum IgE for the soluble α-
ELISA after at least 35 days storage at 4or-20℃. Serum
IgE levels of five samples from normal subjects were 
valuated by the both ELISA systems every 7 days as 
shown in Fig. 3. The IgE values in each serum sample 
estimated by both ELISA systems remained almost 
cons ant during the indicated preservation periods at
both temperatures(4 or-20℃),although the I E values
estim ted by he soluble α-ELISA were substantially lower
than those obtained with the sandwich-ELISA. These
results indicate that serum IgE was stable for binding to
the Fc∈RIα chain under these conditions for at least 35
Fig. 2 Compatibility of the soluble α- and sandwich-ELISA systems.Comparisonofthe calibration curves f r IgE measurement when
the reagents were exchanged between these two ELISA systems.
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Fig. 3 Stability of serum IgE for binding to the Fc∈RIa.IgE levels in sera obtained from five normal subjects were measured by
soluble α-ELISA (filled symbols) and sandwich-EldSA (open symbols) at the indicated time periods (every 7 days)under storage at
(a) 4 or (b)-20℃ and were compared between each ELISA to examine the stability of serum IgE.The IgE values of day 0 represent
those of freshly obtained sera.
Fig. 4 Relationship between Fc∈RI-bindable IgE and total
IgE.The serum IgE values measured by the soluble α-ELISA
(Fc∈RI-bindable IgE) were compared to those measured by the
sandwich-ELISA (total IgE).(y=5.218x+66.465;x(ng/mL),
Fc∈RI-bindable IgE estimated by the soluble α-ELISA;y(ng/mL),
total IgE estimated by the sandwich-ELISA;r=0.581,P<0.01).
days.Therefore,we stored sample sera at-20℃ until
use.Interassay variation of IgE values estimated by
soluble α-ELISA was less than 5%(data not shown).
Evaluation of Fc∈RI-bindable IgE in sera by
soluble α-ELISA
We estimated serum IgE levels by both soluble α- and
conventional sandwich-ELISA and compared each IgE
value between these two different ELISA systems.We
observed a positive correlation between the IgE values
estimated by each ELISA system (r=0.581,P<0.01).
However,as already mentioned,serum IgE values
estimated by the soluble α-ELISA were significantly lower
than those measured by the conventional sandwich-ELISA 
(Fig. 4). This discrepancy between the two ELISA systems 
was strikingly larger when we evaluated hyper-IgE sera. 
In hyper-IgE sera, in which total IgE values were over
3000ng/mL,the Fc∈RI-bindable fractions were less than
10%. In most patients' sera, this ratio was less than 50% 
(the largest population had a distribution of 20-40%).
In only two cases was the Fc∈RI-bindable fraction more
than 80%.
Effect of soluble Fc∈RII/CD23 on IgE binding to
Fc∈RI
The levels of the soluble Fc∈RII/CD23 in the sample sera
ranged from 7 to 289ng/mL and did not correlate
with either the levels of total or Fc∈RI-bindable IgE.We
also examined the dose-dependent effect of soluble
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Fc∈RII/CD23 on IgE-binding to Fc∈RI,as described in
Methods.Even 100-fold the molar excess of soluble
CD230 ver the coated-soluble α could not inhibit
IgE-binding.
DISCUSSION
As functional IgE that can elicit type I allergy should be
the IgE that can bind to the cell surface Fc∈RI,it would be
useful to estimate Fc∈RI-bindable IgE levels in sera for a
more detailed analysis of the allergic state.We therefore
developed a novel ELISA to detect Fc∈RI-bindable IgE
using soluble α ,which is a recombinant soluble form of
the human Fc∈RIα ectodomain produced by CHO
transfectants.23 Soluble α can bind IgE with the same high
affinity as that of native Fc∈RI on the cell surface.19,23 We
determined the binding affinity of soluble α for IgE using
surface plasmon resonance (BIA core system;Pharmacia,
Uppsala,Sweden).For several myeloma IgE,a value of
KA(soluble α)=1.2-1.6×1010/mol per L was obtained
(C Ra et al.,unpubl.obs.,1996).Furthermore,the
stoichiometry of IgE-binding of soluble α in the liquid
phase has been confirmed to be 1:1.21,23 The capacity of
IgE-binding of soluble α in the solid phase is smaller
than that of soluble α in the liquid phase because
soluble α is randomly coated on the plate.However,
for our purposes,randomly coated soluble α.(90ng
(1.8pmol)/well)is enough to evaluate serum IgE bound
to soluble α (soluble α-ELISA).
Calibration curves of standard IgE (human myeloma
IgE) generated by the soluble α-ELISA correlated well
with standard curves determined by a conventional
sandwich-ELISA using two different anti-human IgE
antibodies,despite he fact that the reagents used in the
two ELISA systems were different,and we confirmed the
compatibility of the soluble α-ELISA with the sandwich-
ELISA by exchanging the reagents used between fihem.As
IgE had been considered to easily degenerate and to lose
its binding activity for the receptor,we examin d the
stability of the binding activity of serum IgE to the
soduble α-coated plate.The binding of the IgE in sera
stored at 4or-20℃ did not change for at least 35 days
in the soluble α-ELISA system.Using this newly developed
soluble α-ELISA to detect Fc∈RI-bindable IgE,we
evaluated the fraction of Fc∈RI-bindable IgE in patients'
sera.When we compared the IgE values obtained with
the soluble α-ELISA system with the values obtained with
the sandwich-ELISA (total serum IgE),there was a Iarge
discrepancy in the IgE values between the two ELISA
systems.In most patients' sera,the proportion of
soluble α-bindable IgE was less than 50% of the total IgE,
although the absolute IgE values showed a positive
correlation in these two ELISA systems.
It is known that the binding of IgE to the receptor is
easily lost at high temperatures.We therefore estimated
IgE values in heat-inactivated sera by both ELISA systems.
n all of sera,approximately 90% of IgE binding to
soluble α was lost by treatment at 56℃ for 30min and
almost 100% was lost by treatment at the same
temperature for 2h. By sandwich-ELISA,almost the same
reduction in IgE values after heat-inactivation was
obtained, xcept for some hyper-IgE sera in which some
IgE was still detected. Therefore,it is unlikely that the
differenc s obtained in IgE values between the two ELISA
system  are due to the degeneration of IgE molecules.
These results suggest that there may be some factors in
these ser (especially n hyper-IgE sera),such as anti-IgE
and/or anti-Fc∈RI autoantibodies,that may block IgE
binding to Fc∈RI and/or structurally Fc∈RI non bindable
IgE.Soluble Fc∈RII/CD23 seems to be one of the
candidates for a factor that inhibits IgE-binding to Fc∈RI.11
However,even a 100-fold molar excess of soluble
Fc∈RII/CD23 over so uble α could not block IgE binding
to the soluble α-coated plate (data not shown)and the
level f soluble Fc∈RII/CD23 in the patients' sera ranged
from 7 to 289ng/mL.Anti-IgE autoantibodies have been
reported to significantly increase in the sera of patients
with bronchial asthma and atopic dermatitis and to occur
as immune complexes with IgE in these sera.6-9 If the
re gnition sites of these anti-IgE autoantibodies localize
within the C∈3 domain of the Fc∈ chain,which is t e
binding site of IgE to Fc∈RI,these anti-IgE autoantibodies
will be able to block IgE binding to Fc∈RI.
In cont ast,anti-Fc∈RIα chain autoantibodies were
detec ed in the sera of chronic urticaria patients at a high
fr qu ncy and were elucidated to trigger basophil
degranulation.10 We also detected anti-Fc∈RIα auto-
antibodies in the sera of patients with atopic dermatitis,
which inhibited IgE binding to Fc∈Rlα (S Hayashi et al.,
unpubl.obs.,1996).As the IgE binding site on the
Fc∈RIα ectodomain is mainly localized to the
econd immun globuyin-homologous domain,if these
autoantibodies recognize around this site,they will block
IgE binding.If soluble forms of the Fc∈RIα chain occur,
which would maintain the IgE-binding capacity of the
s ra,they may also contribute to The blocking of IgE
binding to the receptor.There are s v ral other molecules
reported that can also interfere with IgE binding to
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thereceptor,suchasthe60kDaIgE-bindingcomponent
intheseraofpatientswithatopicdermatitis12and
EBP/Mac-2secretedfrommacrophages.,3-16SerumIgE
valuesestimatedbyoursolublea.一ELISAmayreflect
theinfluencesofsuchserumfactors,includingasyet
undefinedfactors.Iftherearesomestructuralchangesin
serumIgEofsomepatients,thesewillalsohaveaneffect
ontheIgEvaluesmeasuredbythesolublea-ELISA
system.Inparticular,structuralchangesintheCE3
domain(thebindingsiteforFcERIa),intheprimary
sequenceand/orincarbohydratemodificationmayexert
someeffectonthebindingofIgEtothereceptor.
WhateverthefactorsarethataffectthebindingofIgE,we
canexpecttoacquireafurtherinsightintotheallergic
statesbyestimatingFcERI-bindableserumIgE.
Inthepresentstudywehavereportedonatrialto
establishasolublea-ELISAsystemtoestimateFcERI-
bindableserumIgEwithoutregardtoantigenspecificity.
Es†ima†ionofFc∈R|bindable-lgEby〇ursolubleα 蟻ELISA
systemrevealedthatallserumIgEdoesnotnecessarily
bindtoFcERI.Withregardtotheaforementionedfactors,
furtherinvestigationsofamolecularnaturewillhaveto
beperformedinfuture.Inthemeantime,wearetryingto
developothersystemstoevaluateallergen-specificand
FcERI-bindableIgEthatismostcriticalfortheactivation
ofmastcellsinallergicreactions(CRaetal.,unpubl.
obs.,1996).
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